Skip to content

Electrical stimulation for craving and brain changes in alcohol use disorder

"Effect of adjunctive HD-tDCS on cue related craving and brain Glutamate and GABA at DLPFC among patients with alcohol dependence syndrome: An 1H-fMRS based randomized sham controlled study."

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/036055
Enrollment
40
Registered
2021-08-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F102- Alcohol dependence

Interventions

Intervention1: Active high definition transcranial direct current stimulation: The central active electrode will be placed over the left dorsolateral prefrontal cortex that is marked by 5 cm laterall

Sponsors

Central Institute of Psychiatry
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with mental and behavioural disorder due to use of alcohol dependence syndrome, currently using the substance (F10.24) as per international classification of diseases 10th (ICD-10) clinical description and diagnostic guidelines (WHO, 1993) 2.Male 3 Age between 18 and 50 yrs 4. Ready to give informed consent. 5.Clinical institute withdrawal assessment for alcohol revised (CIWA-ar) protocol score less than 10. 6. Patients on tab naltrexone 50mg/day as an anticraving agent.

Exclusion criteria

Exclusion criteria: 1. Not willing to give consent 2.Any other co-morbid substance abuse except nicotine and caffeine 3.Participants having any co-morbid psychiatric disorders. 4. Participants with hepatic derangements or impaired liver function test (LFT). 5. Participants having any contraindication for undergoing HD-tDCS and fMRS study.

Design outcomes

Primary

MeasureTime frame
Glutamate and GABATimepoint: Baseline (CIWA-Ar10) and after end of sessions

Secondary

MeasureTime frame
OCDUS, ACQ,Timepoint: Baseline (CIWA-Ar10) and after end of sessions

Countries

India

Contacts

Public ContactDr Sanjay Kumar Munda

Central Institute of Psychiatry

souravpsy@gmail.com79033022259

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026